Search Results for 'Dtg Access'

Dtg Access published presentations and documents on DocSlides.

Progressive rises in weight and clinical obesity for TAF/FTC+DTG and TDF/FTC+DTG versus TDF/FTC/EFV: ADVANCE and NAMSAL trials

Progressive rises in weight and clinical obesity for TAF/FTC+DTG and TDF/FTC+DTG versus TDF/FTC/EFV: ADVANCE and NAMSAL trials

by luanne-stotts

Progressive rises in weight and clinical obesity ...

DTG + 3TC versus DTG + TDF-FTC as Initial ART

DTG + 3TC versus DTG + TDF-FTC as Initial ART

by della

GEMINI 1 and GEMINI 2: Week 48 Data. DTG + 3TC . v...

DTG + TAF/FTC vs DTG + TDF/FTC vs EFV/TDF/FTC

DTG + TAF/FTC vs DTG + TDF/FTC vs EFV/TDF/FTC

by iris

ADVANCE. . Design. Primary endpoint. Proportion ...

Progressive rises in weight and clinical obesity for TAF/FTC+DTG and TDF/FTC+DTG versus TDF/FTC/EFV

Progressive rises in weight and clinical obesity for TAF/FTC+DTG and TDF/FTC+DTG versus TDF/FTC/EFV

by kylo

Andrew Hill, Francois Venter, Eric . Delaporte. , ...

DTG-Based Regimens Are Active in INI-Naive Patients With a

DTG-Based Regimens Are Active in INI-Naive Patients With a

by trish-goza

Jim Demarest. ,. 1. Mark Underwood,. 2. Marty S...

Switch to DTG/ABC/3TC

Switch to DTG/ABC/3TC

by karlyn-bohler

STRIIVING . Study. Design. Endpoints. Primary: pr...

Superior Efficacy of Dolutegravir (DTG) Plus

Superior Efficacy of Dolutegravir (DTG) Plus

by celsa-spraggs

2 Nucleoside Reverse Transcriptase Inhibitors (NR...

Switch to DTG/3TC TANGO Design

Switch to DTG/3TC TANGO Design

by lam

Endpoints. Primary: proportion of patients with HI...

DURABLE EFFICACY OF DOLUTEGRAVIR (DTG) PLUS LAMIVUDINE (3TC) IN ANTIRETROVIRAL TREATMENT

DURABLE EFFICACY OF DOLUTEGRAVIR (DTG) PLUS LAMIVUDINE (3TC) IN ANTIRETROVIRAL TREATMENT

by jasmine

–. NAIVE ADULTS WITH HIV-1 INFECTION: 96-WEEK RE...

DTG/3TC 1st line (GEMINI)

DTG/3TC 1st line (GEMINI)

by oryan

ARV . strategies. DOR > DRV/r 1st line. (DRIVE-...

DTG vs LPV/r (DAWNING): Efficacy

DTG vs LPV/r (DAWNING): Efficacy

by winnie

by Baseline NRTI Resistance . and Second-Line NRTI...

SWITCHING TO DTG/3TC FIXED-DOSE COMBINATION (FDC) IS NON-INFERIOR TO CONTINUING A TAF-BASED REGIMEN

SWITCHING TO DTG/3TC FIXED-DOSE COMBINATION (FDC) IS NON-INFERIOR TO CONTINUING A TAF-BASED REGIMEN

by jacey

1. ViiV Healthcare, Brentford, UK; . 2. Centre Hos...

Comparison of INSTI vs PI

Comparison of INSTI vs PI

by conchita-marotz

FLAMINGO. GS-236-0103. ACTG . A5257. WAVES. . De...

Comparison of INSTI vs PI

Comparison of INSTI vs PI

by conchita-marotz

FLAMINGO. GS-236-0103. ACTG A5257. WAVES. ARIA . ...

10 th International Pediatric HIV Workshop

10 th International Pediatric HIV Workshop

by luanne-stotts

and 22. nd. International AIDS Conference . Sele...

Updated WHO Treatment Guidelines &

Updated WHO Treatment Guidelines &

by mitsue-stanley

Data . from other . cohorts and . regions to guid...

1 Fundación Huésped, Buenos Aires, Argentina;

1 Fundación Huésped, Buenos Aires, Argentina;

by aaron

2. Instituto Nacional de Ciencias Médicas y Nutr...

New regimen for $75 a year

New regimen for $75 a year

by tawny-fly

New pricing agreement will speed up access to gen...

Session - Safety of DTG in Pregnancy: Late Breaking Findings, Interpretations, Implications

Session - Safety of DTG in Pregnancy: Late Breaking Findings, Interpretations, Implications

by liane-varnes

July 24 2018 . Overview on Safety of HIV Treatmen...

Opportunities for the use of new ARVs for infants, children and adolescents and updated guidance on

Opportunities for the use of new ARVs for infants, children and adolescents and updated guidance on

by myesha-ticknor

Martina Penazzato MD, PhD. Paediatric lead, HIV D...

Potential safety issue affecting women living with HIV using

Potential safety issue affecting women living with HIV using

by luanne-stotts

dolutegravir. at the time of conception. Meg Doh...

10 th International Pediatric HIV Workshop

10 th International Pediatric HIV Workshop

by faustina-dinatale

and 22. nd. International AIDS Conference . Sele...

C. Orrell , K. Kintu, J.A. Coombs, A. Amara, L. Myer, J. Kaboggoza, B. Simmons, L. Else, C. Heiberg, C. Waitt, S.

C. Orrell , K. Kintu, J.A. Coombs, A. Amara, L. Myer, J. Kaboggoza, B. Simmons, L. Else, C. Heiberg, C. Waitt, S.

by liane-varnes

C. Orrell , K. Kintu, J.A. Coombs, A. Amara, L. ...

Dolutegravir monotherapy

Dolutegravir monotherapy

by alexa-scheidler

Dolutegravir monotherapy vs. dolutegravir/ abac...

Heather Watts MD Director of HIV Prevention, Program Quality Team

Heather Watts MD Director of HIV Prevention, Program Quality Team

by alida-meadow

Heather Watts MD Director of HIV Prevention, Pro...

1 Queen Mary University, London, United Kingdom;

1 Queen Mary University, London, United Kingdom;

by trish-goza

1 Queen Mary University, London, United Kingdom; ...

What’s New in WHO Treatment Guidelines

What’s New in WHO Treatment Guidelines

by aaron

July 23 2018 . What We Know About Safety Signals ...

Comparison of INSTI vs EFV

Comparison of INSTI vs EFV

by mediumgeneral

STARTMRK. GS-US-236-0102 . SINGLE. Walmsley. S. N...

The SA National PMTCT Guidelines (2019)

The SA National PMTCT Guidelines (2019)

by cleminal

Outline. The ideal PMTCT pathway . Detail of new i...

Comparison of INSTI vs INSTI

Comparison of INSTI vs INSTI

by mediumgeneral

QDMRK. SPRING-2. ONCEMRK. GS-US-380-1489. GS-US-38...

WHO ARV Forecasting Meeting

WHO ARV Forecasting Meeting

by sistertive

Geneva, March 19 - 20 , 2015 1 | Treatment and C...

Paediatric ARV Drug Optimization 3 Review Summary report &

Paediatric ARV Drug Optimization 3 Review Summary report &

by neoiate

*\n\b...

HIV History successes and lessons learned

HIV History successes and lessons learned

by linda

PADO-Dr Martina Penazzato MD MSc PhDPaediatricHIV ...

Clinical considerations for the

Clinical considerations for the

by helene

introduction . of . DTG. Nandita Sugandhi. ICAP at...

CROI 2019: ARV for Prevention and Treatment, HIV Pathogenesis, and Cure

CROI 2019: ARV for Prevention and Treatment, HIV Pathogenesis, and Cure

by brown

Joseph J. Eron, Jr, MD. Professor of Medicine. Uni...

Meg Doherty MD MPH PhD 23 July 2018

Meg Doherty MD MPH PhD 23 July 2018

by jordyn

WHO HQ. The role of DTG based regimens in first- a...

Country Experience in Monitoring New

Country Experience in Monitoring New

by fauna

ARVs: Focus on Toxicity Monitoring . and Surveill...

Neuropsychiatric manifestations and

Neuropsychiatric manifestations and

by Mindbender

sleep disturbances in children and adolescents ran...

Effect of dolutegravir on folate and vitamin B12 status among HIV-infected children and adolescents

Effect of dolutegravir on folate and vitamin B12 status among HIV-infected children and adolescents

by ethlyn

Linda Barlow-Mosha*. 1. , Grace Miriam . Ahimbisib...

What’s new in the 2019 WHO Guidelines:

What’s new in the 2019 WHO Guidelines:

by elina

Dolutegravir based regimens in first- ad second-li...